CNTA Centessa Pharmaceuticals PLC - ADR
164
$8.35
$0.40
(4.57%)
| Watchers | 164 |
| 52-Wk Low | $4.11 |
| 52-Wk High | $12.45 |
| Market Cap | $839.02M |
| Volume | 293,347.00 |
| 52-Wk High | $12.45 |
| 52-Wk Low | $4.11 |
CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023InvestorPlace • about 2 months ago
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
The post...
Share to Feed
Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4Related Stocks: CNTA...
Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...
This indicator may be signaling CNTA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
Related Stocks: CNTA...
This indicator may be signaling that CNTA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This indicator may be signaling CNTA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...
In recent trading, shares of Centessa Pharmaceuticals PLC (CNTA) have crossed above the average analyst 12-month target price of 10.50, changing hands for 10.75/share. When a stock reaches...
This indicator may be signaling that CNTA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
Centessa Pharmaceuticals plc (NASDAQ:CNTA Get Free Report) shares were down 4% on Monday . The company traded as low as $10.47 and last traded at $10.59. Approximately 8,254 shares traded...